On September 30, 2025, Faraday Future Intelligent Electric Inc. (FF) announced the completion of a strategic investment in NASDAQ-listed company Qualigen Therapeutics, Inc. (QLGN), totaling approximately $41 million. Among this, FF led the investment with approximately $30 million, FF's founder and Co-CEO, Jia Yueting, personally invested around $4 million, with other investors also participating. After the investment, QLGN will focus on businesses related to Crypto and Web3.